Cargando…

Simvastatin Augmentation for Patients With Early-Phase Schizophrenia-Spectrum Disorders: A Double-Blind, Randomized Placebo-Controlled Trial

Schizophrenia-spectrum disorders (SSD) are associated with increased inflammatory markers, both in brain and periphery. Augmentation with drugs that lower this pro-inflammatory status may improve clinical presentation. Simvastatin crosses the blood-brain barrier, has anti- inflammatory and neuroprot...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sommer, Iris E, Gangadin, Shiral S, de Witte, Lot D, Koops, Sanne, van Baal, C, Bahn, Sabine, Drexhage, Hemmo, van Haren, N E M, Veling, Wim, Bruggeman, R, Martens, Peter, Wiersma, Sybren, Veerman, Selene R T, Grootens, Koen P, van Beveren, Nico, Kahn, Rene S, Begemann, Marieke J H
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2021
Materias:	Regular Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8266622/ https://www.ncbi.nlm.nih.gov/pubmed/33608711 http://dx.doi.org/10.1093/schbul/sbab010

Ejemplares similares

Inflammatory monocyte gene signature predicts beneficial within group effect of simvastatin in patients with schizophrenia spectrum disorders in a secondary analysis of a randomized controlled trial
por: Aichholzer, Mareike, et al.
Publicado: (2022)

Diagnostic model development for schizophrenia based on peripheral blood mononuclear cell subtype-specific expression of metabolic markers
por: Zaki, Jihan K., et al.
Publicado: (2022)

Longitudinal clinical and functional outcome in distinct cognitive subgroups of first-episode psychosis: a cluster analysis
por: Oomen, Priscilla P., et al.
Publicado: (2023)

To continue or not to continue? Antipsychotic medication maintenance versus dose-reduction/discontinuation in first episode psychosis: HAMLETT, a pragmatic multicenter single-blind randomized controlled trial
por: Begemann, Marieke J. H., et al.
Publicado: (2020)

META-ANALYSES ON DOUBLE-BLIND RCTS ADDING DRUGS WITH ANTI-INFLAMMATORY PROPERTIES TO ANTIPSYCHOTIC MEDICATION
por: Sommer, Iris, et al.
Publicado: (2014)

Psychological Symptoms in Primary Immunodeficiencies: a Common Comorbidity?
por: Manusama, Olivia R., et al.
Publicado: (2022)

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction: Who Benefits Most? A Systematic Review
por: Batalla, Albert, et al.
Publicado: (2019)

Simvastatin augmentation for recent-onset psychotic disorder: A study protocol
por: Begemann, Marieke J.H., et al.
Publicado: (2015)

Inflammatory cytokines and growth factors were not associated with psychosis liability or childhood trauma
por: Counotte, Jacqueline, et al.
Publicado: (2019)

Atopy Increases Risk of Psychotic Experiences: A Large Population-Based Study
por: Begemann, Marieke J.H., et al.
Publicado: (2019)

Women with Schizophrenia-Spectrum Disorders After Menopause: A Vulnerable Group for Relapse
por: Sommer, Iris E, et al.
Publicado: (2022)

T12. VITAMIN D STATUS AND PSYCHOTIC DISORDER: ASSOCIATIONS WITH CLINICAL VARIABLES AND RISK FACTORS
por: van der Leeuw, Christine, et al.
Publicado: (2018)

Prednisolone versus placebo addition in the treatment of patients with recent-onset psychotic disorder: a trial design
por: Nasib, Lyliana G., et al.
Publicado: (2020)

Association between gut permeability, brain volume, and cognition in healthy participants and patients with schizophrenia spectrum disorder
por: Scheurink, Toon Anton Willem, et al.
Publicado: (2023)

Altered fractalkine cleavage potentially promotes local inflammation in NOD salivary gland
por: Wildenberg, Manon E, et al.
Publicado: (2008)

Thymosin α1: a novel therapeutic option for patients with refractory chronic purulent rhinosinusitis
por: Dalm, Virgil, et al.
Publicado: (2013)

T Cell Deficits and Overexpression of Hepatocyte Growth Factor in Anti-inflammatory Circulating Monocytes of Middle-Aged Patients with Bipolar Disorder Characterized by a High Prevalence of the Metabolic Syndrome
por: Vogels, Rogier J., et al.
Publicado: (2017)

The association between antibodies to neurotropic pathogens and schizophrenia: a case-control study
por: de Witte, Lot D, et al.
Publicado: (2015)

Monocyte Gene-Expression Profiles Associated With Childhood-Onset Type 1 Diabetes and Disease Risk: A Study of Identical Twins
por: Beyan, Huriya, et al.
Publicado: (2010)

Incorporation of simvastatin in PLLA membranes for guided bone regeneration: effect of thermal treatment on simvastatin release
por: Castro, Antonio G. B., et al.
Publicado: (2018)

The association between antibodies to neurotropic pathogens and bipolar disorder: A study in the Dutch Bipolar (DB) Cohort and meta-analysis
por: Snijders, Gijsje J. L. J., et al.
Publicado: (2019)

Reduced specialized processing in psychotic disorder: a graph theoretical analysis of cerebral functional connectivity
por: Peeters, Sanne C. T., et al.
Publicado: (2016)

The Kinetics of Plasmacytoid Dendritic Cell Accumulation in the Pancreas of the NOD Mouse during the Early Phases of Insulitis
por: Welzen-Coppens, Jojanneke M. C., et al.
Publicado: (2013)

Monocyte, macrophage and mast cell-derived PDGF control inflammation, tissue remodelling and autoimmunity in the pathophysiology of Graves’ ophthalmpathy
por: van Steensel, Leendert, et al.
Publicado: (2011)

The Gene Expression Profile of CD11c(+)CD8α(−) Dendritic Cells in the Pre-Diabetic Pancreas of the NOD Mouse
por: Beumer, Wouter, et al.
Publicado: (2014)

Evidence That Transition from Health to Psychotic Disorder Can Be Traced to Semi-Ubiquitous Environmental Effects Operating against Background Genetic Risk
por: van Nierop, Martine, et al.
Publicado: (2013)

Effects of Air Pollution on Lung Innate Lymphoid Cells: Review of In Vitro and In Vivo Experimental Studies
por: Estrella, Bertha, et al.
Publicado: (2019)

Characterization of macrophages from schizophrenia patients
por: Ormel, Paul R., et al.
Publicado: (2017)

Expression of GAD67 and Novel GAD67 Splice Variants During Human Fetal Pancreas Development: GAD67 Expression in the Fetal Pancreas
por: Korpershoek, Esther, et al.
Publicado: (2007)

Cognitive Adaptation Training Provided to Chronically Hospitalized Patients with Schizophrenia in The Netherlands: Two Case Reports
por: Quee, Piotr J., et al.
Publicado: (2012)

Neural Correlates of Emotion Regulation in Patients with Schizophrenia and Non-Affected Siblings
por: van der Meer, Lisette, et al.
Publicado: (2014)

Ezetimibe/simvastatin vs simvastatin in coronary heart disease patients with or without diabetes
por: Rotella, Carlo M, et al.
Publicado: (2010)

Transcranial direct current stimulation as a treatment for auditory hallucinations
por: Koops, Sanne, et al.
Publicado: (2015)

Severe Rhabdomyolysis Associated with Simvastatin and Role of Ciprofloxacin and Amlodipine Coadministration
por: De Schryver, Nicolas, et al.
Publicado: (2015)

Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester
por: Reulen, Sanne WA, et al.
Publicado: (2009)

S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression
por: Ambrée, Oliver, et al.
Publicado: (2015)

Efficacy of Sertraline Plus Placebo or Add-On Celecoxib in Major Depressive Disorder: Macrophage Migration Inhibitory Factor as a Promising Biomarker for Remission After Sertraline—Results From a Randomized Controlled Clinical Trial
por: Simon, Maria S., et al.
Publicado: (2021)

Premature T cell aging in major depression: A double hit by the state of disease and cytomegalovirus infection
por: Simon, Maria S., et al.
Publicado: (2023)

Type 2 Diabetes Monocyte MicroRNA and mRNA Expression: Dyslipidemia Associates with Increased Differentiation-Related Genes but Not Inflammatory Activation
por: Baldeón R., Lucy, et al.
Publicado: (2015)

Study on inflammation-related genes and microRNAs, with special emphasis on the vascular repair factor HGF and miR-574-3p, in monocytes and serum of patients with T2D
por: Baldeón Rojas, Lucy, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_0224qc9055p5n7s8imbon1bj73